Hungarian Drug Maker Triumphs Over Merck

Law360, New York (February 20, 2007, 12:00 AM EST) -- A Hungarian court has reportedly ruled that the country’s largest drug maker, Richter Gedeon, did not infringe Merck & Co. Inc.’s patent by marketing the osteoporosis drug Sedron.

The Municipal Court in Budapest also said Monday that Richter Gedeon was entitled to damages because it was forced to pull Sedron from the shelves between June 2005 and January 2006.

Though Richter previously estimated the damages of the preliminary injunction at over 3 billion forints ($15.6 million), according to Dow Jones, it did not say how much...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.